Recombinant Human Anti-5OH-DF Soluble TCR (C-Cys) (VS-0622-YF4052) (CAT#: VS-0622-YF4052)
Human TCR recognizes 5OH-DF peptide (5-hydroxydiclofenac) in the context of human MR1. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- 5OH-DF
- Epitope
- 5-hydroxydiclofenac
- MHC
- human MR1
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- 5OH-DF; 5-hydroxydiclofenac
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4052. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, Cyt, Stim, PP, Agonist
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: ELISA
Application: FuncS, Inhib, IP, ELISA
Application: ELISA, IHC, FC, WB, IF, IA
Application: WB, IHC, ELISA, FC
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, WB, FC, IHC, IP
Application: Neut, ELISA, WB, SPR, IF, EM
Application: Inhib, FC, WB
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.